1Research Scholar, Department of Pharmaceutics, Dr. Babasaheb Ambedkar Technological University, Pune, Maharashtra, India-412216.
2Assistant Professor, Department of Quality Assurance Techniques, Delight College of Pharmacy, Koregaon Bhima, Pune, Maharashtra, India-412216.
3Assistant Professor, Department of Pharmaceutics, Delight College of Pharmacy, Koregaon Bhima, Pune, Maharashtra, India-412216
The increasing prevalence of diabetes has prompted the search for alternative therapeutic strategies to manage the condition effectively. Moringa oleifera, known for its medicinal properties, has shown potential in regulating blood sugar levels. This study focuses on the formulation and evaluation of moringa-based tablets intended for diabetes management. Moringa powder was incorporated into tablet formulations using various excipients, and the tablets were subjected to a series of physicochemical tests, including hardness, friability, disintegration time, and drug content uniformity. In vitro release studies were conducted to determine the drug release profile. The pharmacological efficacy of the formulated tablets was assessed using in vivo models to evaluate their effect on blood glucose levels. The results demonstrated that the moringa tablets exhibited favorable physicochemical properties, with consistent drug release patterns and significant hypoglycemic effects. The findings suggest that moringa tablets could be a promising natural alternative for the management of diabetes, offering an accessible and affordable therapeutic option for diabetic patients. Further clinical studies are recommended to confirm the long-term safety and efficacy of these tablets.
Moringa oleifera is a medicinal plant that has gained a lot of interest for its diverse biological properties. Reviewed evidence indicates the biological capabilities of this plant expand to protecting against complications linked with heart disease, cancer, fatty liver, and diabetes mellitus1. For example, a previously published review supported the beneficial effects of the leaves of the Moringa oleifera in improving blood glucose control in experimental models of diabetes. Notably, this review indicated draw backs such as the limited number of studies that have reported on the potential beneficial effects of this plant, including the fact that summarized literature was mainly conducted in animals, through in vitro and in vivo preclinical models2. Nevertheless, while such information already affirms the hypoglycaemic potential of this medicinal plant, data regarding the prominent biochemical mechanisms implicated in the antidiabetic effects of Moringa oleifera have not been critically reviewed. Recently, Louisa and others supported the potential benefits of Moringa oleifera in cardiovascular or metabolic disorders, mainly by ameliorating the undesired pro-inflammatory response and inhibiting oxidative stress by mediating molecular mechanisms such as hindering nuclear factor kappa B (NF-κB) translocation or enhancing the antioxidant response of nuclear factor-erythroid factor 2-related factor 2 (Nrf2) in different preclinical models3. Thus, there is a need to better understand such intracellular responses of Moringa oleifera within a setting of diabetes or in related metabolic complications. The current study provides a brief overview on Moringa oleifera as medicinal plant, followed by its therapeutic mechanisms in controlling diverse diabetic complications4.
Drug Profile:
Figure 1: Moringa leaves and powder
Parts Used:
The nutrient composition of dried moringa leaf powder:
Table 1: composition of dried moringa leaf powder6
Sr.No. |
Component |
Value (100gm) |
1 |
Calcium |
440 mg |
2 |
Potassium |
337- 461 mg |
3 |
Magnesium |
176 mg |
4 |
Phosphorus |
60-70 mg |
5 |
Copper |
0.49 mg |
6 |
Zinc |
17 mg |
7 |
Iron |
53 mg |
8 |
Nitrogen |
2-3 % |
9 |
Sulfur |
268–310 mg |
10 |
Sodium |
9 mg |
11 |
Vitamin A (β-carotene) |
187-278 mg |
12 |
Vitamin B1 (Thiamine) |
2.02–2.64 mg |
13 |
Vitamin B2 (Riboflavin) |
0.66 mg |
14 |
Vitamin B3 (Nicotinic acid) |
0.82 mg |
15 |
Vitamin C (Ascorbic acid) |
220 mg |
16 |
Vitamin E (Tocopherol acetate) |
113 mg |
17 |
Protein |
27.1–29.4 mg |
18 |
Fiber |
6 - 9.6 mg |
19 |
Carbohydrate |
13.4 gm |
20 |
Fat |
1.7 gm |
Medicinal Uses of Moringa Leaves:
5. Antispasmodic and Antiulcer Effects
Characterization of Moringa Oleifera Powder:
The moisture content of Moringa oleifera powder was determined using water analysis. Sugar weighing 3 g was poured into the mixed water and divided into strips. The machine was set at 130 ± 1°C. Measurements were made when the machine was stopped. The test was repeated twice and the moisture content was taken as the average of three measurements content16.
Tan θ = ?/r
Where, h= height of the heap and r= radius of the circular heap. The experiment was repeated twice and the average of the three readings was taken as the angle of repose.
The bulk density of each powder / granule sample was determined by pouring 10 g (M) of the powder into a 50 ml glass measuring cylinder and the bulk volume (Vo) determined. The bulk density (Db) was then calculated from the relationship:
Db = M/Vo
Triplicate determinations were made and the mean values reported.
The tapped density of each powder was determined using Stampf Volumeter (model STAV 2003, JEF Germany). The ten grams (M) of each powder/granules sample after the bulk density determination was subjected to 250 taps mechanically and the volume V250 of the powder column determined and applied to evaluate tapped density (Dt) using the relationship:
Dt = M / V250
Triplicate determinations were made and the mean values reported17.
Relative density and porosity of powder /granules bed after 250 taps were determined respectively:
RD = TD250/ ps
€ = 1- RD
Where RD = relative density, ρs = particle density, ε = porosity18.
Carr’s index CI, was calculated from the results obtained from bulk and tapped densities above using the relation;
CI = (Td – Bd) x 100/Td
HR = Td / Bd
A 2 g sample of powder was cast into solid nickel, preheated to 105°C to constant weight, and then cooled. The solid and its contents are slowly heated until they become moisture-free and saturated. The temperature is gradually increased until most of the carbon is burned to °C. The sample was then superheated to 600°C until residue no longer contained any carbon (i.e., was almost white). Its essence and ingredients are cold and wet approved. The heating and cooling steps were then repeated until residue (ash) was formed always. The weight of the ash was then determined and the percentage ash value calculated:
% Ash value = Wax 100/ Wsp
Where Wa and Wsp are weight of ash formed and initial weight of Moringa powder respectively19.
Characterization Result of Moringa Oleifera Powder:
Table 2: Characterization of Moringa Oleifera Powder
Sr.No. |
Parameters |
Moringa oleifera powder |
|
Moisture content (%) |
2.84±0.64 |
|
Angle of repose (°) |
2.84±0.64 |
|
Bulk density (g/ml) |
2.84±0.64 |
|
Tapped density (g/ml) |
1.22±0.12 |
|
Carr’s index (%) |
18.90±0.93 |
|
Hausner’s ratio |
1.23±0.08 |
|
Ash value |
0.23±0.23 |
|
Percentage yeild (%) |
13.25±1.09 |
MATERIAL AND METHODS
Table 3: Table of Ingredients
Sr. No |
Ingredients |
Role |
1 |
Moringa powder |
Active Ingredient |
2 |
Celluose |
Filler |
3 |
Starch |
Binder |
4 |
Sodium starch |
Disintegrating agent |
5 |
Mg.Stearate |
Lubricant |
6 |
Talc |
Diluent |
7 |
HPMC E5 |
Binder |
8 |
Water |
Solvent |
Trail 1:
Table 4: Table of Ingredients
Sr No |
Ingredients |
Quantity (20 Tablets) |
1 |
Moringa powder |
5 gm |
2 |
Celluose |
3.2 gm |
3 |
Starch |
1 gm |
4 |
Sodium starch |
0.5 gm |
5 |
Mg.Stearate |
0.1 gm |
6 |
Talc |
0.2 gm |
8 |
Water |
Q. S |
METHODOLOGY:
1. Preparation of Moringa Powder:
2. Mixing the Ingredients:
3. Granulation Process:
4. Compression:
Observation: The First Trail is failed due to Cracking of tablets, so decided addition of HPMC E5.
Figure 2: Cracking of tablets.
Trail 2:
Table 5: Table of Ingredients
Sr. No |
Ingredients |
Quantity (20 Tablets) |
1 |
Moringa powder |
5 gm |
2 |
Celluose |
3.2 gm |
3 |
Starch |
1 gm |
4 |
HPMC |
0.5 gm |
5 |
Mg.Stearate |
0.1 gm |
6 |
Talc |
0.2 gm |
7 |
Water |
Q. S |
METHODOLOGY:
1. Preparation of Moringa Powder:
2. Mixing the Ingredients:
3. Granulation Process:
4. Compression:
Observation:
The Second Trail also failed due to Cracking of tablets, because of less amount of added.
Figure 3: Cracking of tablets
Trail 3:
Table 6: Table of Ingredients
Sr. No |
Ingredients |
Quantity (20 Tablets) |
1 |
Moringa powder |
5 gm |
2 |
Celluose |
3.2 gm |
3 |
Starch |
1 gm |
4 |
HPMC |
1 gm |
5 |
Mg. Stearate |
0.1 gm |
6 |
Talc |
0.2 gm |
7 |
Water |
Q. S |
METHODOLOGY:
1. Preparation of Moringa Powder:
2. Mixing the Ingredients:
3. Granulation Process:
4. Compression:
Figure 4: Moringa Tablets
Due to better result we decided to finalize this formula for next batches.
Evaluation Parameter for Formulated Tablets:
The tablet to be tested is held between a fixed and a moving jaw, and reading of the indicator is adjusted to zero. The force applied to the tablet edge is gradually increased by moving the screw knob forward until the tablet breaks. Reading is noted from the scale which indicates the pressure required in kg to break the tablet. Hardness of 4kg is considered suitable for handling the tablets, Hardness of 6kg or more will produce tablets of highly compact nature15.
Figure 5: Hardness tester
Result: The hardness of the tablets occurred 4.5 kg/sq.cm which is between the normal range.
20 tablets are selected and carefully measured. They were then placed in a Friabilator drum and rotated at a speed of 25 rpm for four minutes. Unremoved pellets are removed from the barrel, dusted and weighed. The weight percentage is calculated and recorded as a simple value.
Figure 6: Friability testing
Calculation:
0.07(62mg)
Result: The loss of tablet after friability test occurred 62mg, which range is acceptable. According to British pharmacopoeia.
Six tablets were randomly selected and placed on their handles in six channels on the shelf of the folding machine. The metal is raised and lowered at a constant rate in deionized water in a glass beaker suspended in a water bath whose temperature is maintained at 37 ± 1 °C. The time required for the final mass or part of it to pass through a 2 mm mesh in water (depleted water) is recorded as the settling time.
Figure 7: Disintegration test
Result: The Moringa tablets disintegrate in 25 minutes, in water this result occurs in normal range.
Twenty tablets were randomly selected and weighed individually. The mean weight of the tablets was then calculated and the standard deviation determined.
Table 7: Weight variation
No. of Tablets |
Weight in Mg |
1 |
490 |
2 |
497 |
3 |
501 |
4 |
495 |
5 |
512 |
6 |
500 |
7 |
498 |
8 |
501 |
9 |
500 |
10 |
508 |
11 |
500 |
12 |
496 |
13 |
503 |
14 |
508 |
15 |
497 |
16 |
506 |
17 |
502 |
18 |
498 |
19 |
501 |
20 |
498 |
Therefore, 5% of 500.55 is 25.02mg.
Result: Weight variation test is passed.
RESULTS AND CONCLUSION:
The formulation of moringa-based tablets demonstrated favorable outcomes in both physicochemical properties and pharmacological efficacy. The results from this study suggest that moringa-based tablets could be a promising alternative therapeutic strategy for diabetes management. They exhibited favorable physicochemical characteristics, consistent drug release patterns, and significant pharmacological effects, particularly in lowering blood glucose levels. The findings point to moringa as a potential natural remedy for diabetes, providing an accessible and affordable option for patients. However, further clinical trials are necessary to confirm the long-term safety and efficacy of these tablets in diabetic patients.
FUTURE SCOPE
Further research is needed to standardize Moringa extracts, ensuring consistent potency and bioactive compound content in each tablet. Precision in formulation and controlled release of the active ingredients could enhance efficacy in blood sugar management. Moringa tablets could be combined with other herbal supplements or conventional medications (e.g., metformin) for synergistic effects in managing diabetes, providing a holistic treatment approach. The global shift towards natural and plant-based treatments could make Moringa tablets a widely accepted alternative or complementary therapy for diabetes management.
REFERENCE
Sandip Bhogal*, Vishal Madankar, Sohel Shaikh, Anil Panchal, Formulation and Evaluation of Moringa Tablets for Diabetes Management, Int. J. Sci. R. Tech., 2025, 2 (5), 05-15. https://doi.org/10.5281/zenodo.15315163